Mutual of America Capital Management LLC lowered its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 1.4% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 41,326 shares of the financial services provider’s stock after selling 582 shares during the quarter. Mutual of America Capital Management LLC’s holdings in CME Group were worth $11,390,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Webster Bank N. A. boosted its position in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after buying an additional 60 shares during the period. Highline Wealth Partners LLC boosted its position in CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 43 shares during the period. Wayfinding Financial LLC purchased a new stake in shares of CME Group in the 1st quarter worth about $25,000. Cornerstone Planning Group LLC lifted its position in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 55 shares during the period. Finally, Trifecta Capital Advisors LLC lifted its position in shares of CME Group by 59.2% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 42 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Trading Up 2.1%
Shares of CME opened at $267.93 on Monday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market cap of $96.56 billion, a P/E ratio of 25.94, a P/E/G ratio of 6.16 and a beta of 0.41. The company’s fifty day simple moving average is $267.30 and its 200-day simple moving average is $271.40. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were issued a dividend of $1.25 per share. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s dividend payout ratio is presently 48.40%.
Insider Activity
In other news, Director William R. Shepard bought 262 shares of CME Group stock in a transaction that occurred on Thursday, September 25th. The shares were purchased at an average price of $265.19 per share, with a total value of $69,479.78. Following the completion of the acquisition, the director directly owned 258,459 shares in the company, valued at $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the transaction, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 13,043 shares of company stock worth $3,527,956. Company insiders own 0.30% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have recently commented on CME. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a research report on Monday, October 13th. Oppenheimer lifted their price target on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research report on Thursday, July 24th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of CME Group from $276.00 to $266.00 and set a “hold” rating for the company in a report on Thursday, October 9th. Wall Street Zen cut shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Finally, Morgan Stanley boosted their price objective on shares of CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a report on Wednesday, October 1st. Seven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus price target of $283.71.
View Our Latest Research Report on CME
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- What is a Special Dividend?
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.